Rui Branca

About Rui Branca

Rui Branca, With an exceptional h-index of 28 and a recent h-index of 24 (since 2020), a distinguished researcher at Karolinska Institutet, specializes in the field of Biochemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

A suicidal and extensively disordered luciferase with a bright luminescence

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

Development of Oncolytic Adenovirus-Based Vaccine for Personalized Treatment of Malignant Mesothelioma

Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Generation of ENSEMBL-based proteogenomics databases boosts the identification of non-canonical peptides

Bioinformatics analysis of NSCLC multi-omics data

Rui Branca Information

University

Position

___

Citations(all)

2583

Citations(since 2020)

1710

Cited By

1584

hIndex(all)

28

hIndex(since 2020)

24

i10Index(all)

52

i10Index(since 2020)

43

Email

University Profile Page

Google Scholar

Rui Branca Skills & Research Interests

Biochemistry

Top articles of Rui Branca

Title

Journal

Author(s)

Publication Date

A suicidal and extensively disordered luciferase with a bright luminescence

bioRxiv

Fenne Marjolein Dijkema

Marta Iglesia Escarpizo-Lorenzana

Matilde Knapkøien Nordentoft

Hanna Christin Rabe

Cagla Sahin

...

2023/12/22

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR

Science Advances

Francesco Manfredi

Lorena Stasi

Silvia Buonanno

Francesca Marzuttini

Maddalena Noviello

...

2023/12/1

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

Nature Communications

Jacopo Chiaro

Gabriella Antignani

Sara Feola

Michaela Feodoroff

Beatriz Martins

...

2023/11/3

Development of Oncolytic Adenovirus-Based Vaccine for Personalized Treatment of Malignant Mesothelioma

Molecular therapy

Jacopo Chiaro

Gabriella Antignani

Sara Feola

Michaela Feodoroff

Beatriz Martins

...

2023/5/1

Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors

Jacopo Chiaro

Gabriella Antignani

Sara Feola

Michaela Feodoroff

Beatriz Martins

...

2022/11/8

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Elife

Sara Feola

Jacopo Chiaro

Beatriz Martins

Salvatore Russo

Manlio Fusciello

...

2022/3/22

Generation of ENSEMBL-based proteogenomics databases boosts the identification of non-canonical peptides

Bioinformatics

Husen M Umer

Enrique Audain

Yafeng Zhu

Julianus Pfeuffer

Timo Sachsenberg

...

2022/3/1

Bioinformatics analysis of NSCLC multi-omics data

Janne Lehtiö

Taner Arslan

Ioannis Siavelis

Yanbo Pan

Fabio Socciarelli

...

2021/11/22

PeptiCHIP: A novel microfluidic-based chip platform for tumor antigen landscape identification

Sara Feola

Markus Haapala

Karita Peltonen

Cristian Capasso

Beatriz Martins

...

2021/3/3

Immune landscape evaluation of NSCLC clinical samples

Janne Lehtiö

Taner Arslan

Ioannis Siavelis

Yanbo Pan

Fabio Socciarelli

...

2021/11/22

STK11 pathway in vitro validation

Janne Lehtiö

Taner Arslan

Ioannis Siavelis

Yanbo Pan

Fabio Socciarelli

...

2021/11/22

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Nature cancer

Janne Lehtiö

Taner Arslan

Ioannis Siavelis

Yanbo Pan

Fabio Socciarelli

...

2021/11

Charge engineering reveals the roles of ionizable side chains in electrospray ionization mass spectrometry

JACS Au

Mia L Abramsson

Cagla Sahin

Jonathan TS Hopper

Rui MM Branca

Jens Danielsson

...

2021/11/29

Mass spectrometry-based proteomic analysis of NSCLC tumor and biopsy samples

Janne Lehtiö

Taner Arslan

Ioannis Siavelis

Yanbo Pan

Fabio Socciarelli

...

2021/11/22

Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy

Cancers

Karita Peltonen

Sara Feola

Husen M Umer

Jacopo Chiaro

Georgios Mermelekas

...

2021/7/7

Domain expertise–agnostic feature selection for the analysis of breast cancer data

Artificial Intelligence in Medicine

Susanna Pozzoli

Amira Soliman

Leila Bahri

Rui Mamede Branca

Sarunas Girdzijauskas

...

2020/8/1

Immediate adaptation analysis implicates BCL6 as an EGFR-TKI combination therapy target in NSCLC

Molecular & Cellular Proteomics

Yan Zhou Tran

Rezan Minozada

Xiaofang Cao

Henrik J Johansson

Rui M Branca

...

2020/6/1

Ribonucleotide reductase inhibitors suppress SAMHD 1 ara‐CTP ase activity enhancing cytarabine efficacy

EMBO molecular medicine

Sean G Rudd

Nikolaos Tsesmetzis

Kumar Sanjiv

Cynthia BJ Paulin

Lakshmi Sandhow

...

2020/3/6

Key structural motifs balance metal binding and oxidative reactivity in a heterobimetallic Mn/Fe protein

Journal of the American Chemical Society

Effie C Kisgeropoulos

Julia J Griese

Zachary R Smith

Rui MM Branca

Camille R Schneider

...

2020/2/17

See List of Professors in Rui Branca University(Karolinska Institutet)